Imunon, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/35b8aa30-3746-404f-a315-474187e9a2f1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $500.0k | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009604 |
| FY 2021 | $500.0k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008277 |
| FY 2020 | $500.0k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006382 |
| FY 2019 | $500.0k | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004717 |
| FY 2018 | $500.0k | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004184 |
| FY 2017 | $500.0k | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-004184 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).